London stocks ended Monday on a mixed note, as investors weighed economic indicators from the UK and Europe, as well as news that Westminster and Brussels have agreed a 'Brexit reset' deal. The FTSE ...

The FTSE 100 rallied into the close on Monday, ending at best levels for the day, as investors weighed UK-EU reset talks and Moody's US credit rating downgrade. The FTSE 100 index rose 14.75 points, 0 ...

Tanfield said the investment is worth GBP19.1 million. In October 2019, Tanfield said it had received a summons and complaint in Nevada, US that alleged that Xtreme can buy Tanfield's interest in ...

(Alliance News) - Angus Energy PLC on Monday said it has agreed on a non-binding potential deal for the reverse takeover of an unnamed group of producing assets in the Gulf of Mexico.

The JV, Rio Tinto said, will develop and operate a high-grade lithium project in the Salar de Maricunga in Chile. "The agreement is the next step in a broader strategic partnership to strengthen both ...

Kodal said the government of Mali has been "very supportive of the development of Bougouni and this support continues in the ongoing export permit discussions, and it is acknowledged that it is in the ...

The CEO of the Rotherham, South Yorkshire-based regenerator of land for sustainable development said the business has seen "significant" operational momentum across all parts of the business in 2025 ...

(Alliance News) - Anglo Asian Mining PLC on Monday announced that it started production from Gilar, a new underground mine at the Gedabek site in Azerbaijan.

Arecor Chief Executive Sarah Howell said: "We are pleased to partner with Skye Bioscience to support the development of a novel, enhanced formulation of nimacimab, a promising first-in-class candidate ...

Alliance News] - Keir Starmer's UK government has claimed his post-Brexit "reset" will cut red tape for travellers and businesses, boosting the economy by GBP9 billion by 2040. Under the deal struck ...

(Alliance News) - Cora Gold Ltd on Monday said its loss narrowed during 2024 following a reduction in expenses, while the recent rise in gold prices has driven optimism in the firm's outlook for its ...

Rocket Pharmaceuticals is a US-based late-stage biotech firm advancing a pipeline of investigational genetic therapies designed to correct the root cause of complex and rare disorders. The group was ...